Similar articles

Abstract: non-Syndromic Hearing Loss (NSHL) is a common defect in humans. Variants of MARVELD2 at the DFNB49 locus have been shown to cause bilateral, moderate to profound NSHL. However, the role of MARVELD2 in NSHL susceptibility in the chinese population has not been studied. Here we conducted a case-control study in an eastern chinese population to profile the spectrum and frequency of MARVELD2 variants, as well as the association of MARVELD2 gene variants with NSHL. Our results showed that variants identified in the chinese population are significantly different from those reported in Slovak, Hungarian, and Czech Roma, as well as Pakistani families. We identified 11 variants in a cohort of 283 NSHL cases. Through Sanger sequencing and bioinformatics analysis, we found that c.730G>A variant has detrimental effects in the eastern chinese population, and may have relatively high correlation with NSHL pathogenicity.

中国人群中非综合征耳聋相关MARVELD2 (DFNB49)基因新单核苷酸多态性位点分析

[1]Adzhubei I, Jordan DM, Sunyaev SR, 2013. Predicting functional effect of human missense mutations using polyphen-2. Curr Protoc Hum Genet, 76(1):7.20.1-7.20.41.

[2]Babanejad M, Fattahi Z, Bazazzadegan N, et al., 2012. A comprehensive study to determine heterogeneity of autosomal recessive nonsyndromic hearing loss in Iran. Am J Med Genet A, 158A(10):2485-2492.

[3]Chasman D, Adams RM, 2001. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J Mol Biol, 307(2):683-706.

[4]Chishti MS, Bhatti A, Tamim S, et al., 2008. Splice-site mutations in the TRIC gene underlie autosomal recessive nonsyndromic hearing impairment in Pakistani families. J Hum Genet, 53(2):101-105.

[5]Dror AA, Avraham KB, 2009. Hearing loss: mechanisms revealed by genetics and cell biology. Annu Rev Genet, 43:411-437.

[6]Dror AA, Avraham KB, 2010. Hearing impairment: a panoply of genes and functions. Neuron, 68(2):293-308.

[7]Higashi T, Lenz DR, Furuse M, et al., 2013. A “Tric” to tighten cell–cell junctions in the cochlea for hearing. J Clin Invest, 123(9):3712-3715.

[8]Kitajiri SI, Furuse M, Morita K, et al., 2004. Expression patterns of claudins, tight junction adhesion molecules, in the inner ear. Hear Res, 187(1-2):25-34.

[9]Krug SM, Amasheh S, Richter JF, et al., 2009. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell, 20(16):3713-3724.

[10]Mašindová I, Šoltýsová A, Varga L, et al., 2015. MARVELD2 (DFNB49) mutations in the hearing impaired central European Roma population—prevalence, clinical impact and the common origin. PLoS ONE, 10(4):e0124232.

[11]Morton CC, Nance WE, 2006. Newborn hearing screening— a silent revolution. New Engl J Med, 354(20):2151-2164.

[12]Nayak G, Varga L, Trincot C, et al., 2015. Molecular genetics of MARVELD2 and clinical phenotype in Pakistani and Slovak families segregating DFNB49 hearing loss. Hum Genet, 134(4):423-437.

[13]Ng PC, Henikoff S, 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res, 31(13):3812-3814.

[14]Oda Y, Otani T, Ikenouchi J, et al., 2014. Tricellulin regulates junctional tension of epithelial cells at tricellular contacts through Cdc42. J Cell Sci, 127(Pt 19):4201-4212.

[15]Raleigh DR, Marchiando AM, Zhang Y, et al., 2010. Tight junction-associated marvel proteins MarvelD3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell, 21(7):1200-1213.

[16]Ramzan K, Shaikh RS, Ahmad J, et al., 2005. A new locus for nonsyndromic deafness DFNB49 maps to chromosome 5q12.3-q14.1. Hum Genet, 116(1-2):17-22.

[17]Riazuddin S, Ahmed ZM, Fanning AS, et al., 2006. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet, 79(6):1040-1051.

[18]Šafka Brožková D, Laštůvková J, Štěpánková H, et al., 2012. DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population. Clin Genet, 82(6):579-582.

[19]Schraders M, Ruiz-Palmero L, Kalay E, et al., 2012. Mutations of the gene encoding otogelin are a cause of autosomal-recessive nonsyndromic moderate hearing impairment. Am J Hum Genet, 91(5):883-889.

[20]Smith RJH, Bale JF Jr, White KR, 2005. Sensorineural hearing loss in children. Lancet, 365(9462):879-890.

[21]Sterkers O, Ferrary E, Amiel C, 1988. Production of inner ear fluids. Physiol Rev, 68(4):1083-1128.

[22]Teng S, Michonova-Alexova E, Alexov E, 2008. Approaches and resources for prediction of the effects of non- synonymous single nucleotide polymorphism on protein function and interactions. Curr Pharm Biotechnol, 9(2):123-133.

[23]Wang Y, Virtanen J, Xue ZD, et al., 2017. I-TASSER-MR: automated molecular replacement for distant-homology proteins using iterative fragment assembly and progressive sequence truncation. Nucleic Acids Res, 45(W1):W429-W434.

[24]Yang JY, Zhang Y, 2015. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res, 43(W1):W174-W181.

[25]Yang JY, Yan RX, Roy A, et al., 2015. The I-TASSER suite: protein structure and function prediction. Nat Methods, 12(1):7-8.

[26]Zheng J, Ying ZB, Cai ZY, et al., 2015. GJB2 mutation spectrum and genotype-phenotype correlation in 1067 Han Chinese subjects with non-syndromic hearing loss. PLoS ONE, 10(6):e0128691.

[27]List of electronic supplementary materials

[28]Table S1 Primers used in PCR